Management After LDL-C Reduction to Normal Levels

Continuation of Therapy

The American Heart Association recommends continuing the current lipid-lowering therapy that successfully reduced LDL-C to target levels after the LDL-C goal has been reached 1
For patients on statin therapy, the American College of Cardiology recommends maintaining the effective dose that achieved target LDL-C levels 3, 4

The American Academy of Pediatrics recommends monitoring lipid profile every 3-6 months in the first year, then every 6 months in the second year and beyond after the LDL-C goal has been reached 5
Assess for potential medication side effects at each follow-up visit, particularly muscle symptoms that could indicate myopathy, as recommended by the American Academy of Pediatrics 5
Monitor liver function tests (ALT, AST) periodically to ensure medication safety, as recommended by the American Academy of Pediatrics 5

After achieving LDL-C goals, consider addressing other lipid abnormalities, such as high triglycerides or low HDL-C, as recommended by the American Heart Association 1, 3
If triglycerides are elevated, consider treating elevated non-HDL-C with higher doses of statin or adding niacin or fibrate, as recommended by the American Heart Association 1, 3

The American College of Cardiology recommends continuing dietary therapy with reduced intake of saturated fats, cholesterol, and trans-fatty acids 2, 3
Maintain regular physical activity of at least 30 minutes of moderate-intensity activity on most days of the week, as recommended by the American College of Cardiology 2, 3
Continue weight management efforts if BMI is elevated, as recommended by the American Heart Association 1, 2

For children and adolescents who have achieved LDL-C goals, continue to monitor growth and development, as recommended by the American Academy of Pediatrics 5
Continue to assess and counsel for other risk factors such as weight gain, smoking, and inactivity, as recommended by the American Academy of Pediatrics 5

If LDL-C levels rise above target despite adherence to current therapy, consider intensifying therapy, as recommended by the American Heart Association 1, 3
For very high-risk patients, consider further reduction of LDL-C to <70 mg/dL for additional cardiovascular risk reduction, as recommended by the American College of Cardiology 3, 4